Announced Tue, 7 Jul · 17:11 IST
Board meeting on July 13, 2026 to consider Q1 FY27 financial results
Results View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.4%1-day move
₹23.25
prior close
₹24.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5——-0.8-0.4+1.5+9.8+0.3-0.4+1.1————
Up moveDown movePending
AI summary
Vivo Bio Tech has informed BSE that its Board of Directors will meet on Monday, July 13, 2026 at the registered office to consider and approve the Unaudited Standalone and Consolidated Financial Results for the first quarter ended June 30, 2026. The trading window for directors, promoters, designated employees and specified connected persons remains closed till July 15, 2026.
Likely market impact
Routine intimation. Q1 FY27 results to be announced after the board meeting on July 13. No immediate price impact expected.